A Randomised, Double-blinded, Cross-over Study Investigating the Short-term Impact of Liraglutide on Kidney Function in Diabetic Patients
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2016
Price : $35 *
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
- 27 Feb 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.